Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03534193 · ClinicalTrials.gov registry record · NA
Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes
A NA study, sponsored by Hackensack Meridian Health.
- Terminated
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03534193 is a NA study that was terminated before completion, run by Hackensack Meridian Health. The registered enrollment target is 28 participants.
The verdict
NCT03534193, a NA study, was terminated before completion, sponsored by Hackensack Meridian Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This is a prospective, randomized trial to evaluate the effectiveness of using educational modules accessed through a bedside tablet in patients newly diagnosed with Type 1 Diabetes as an adjunct to \*standard Children's Hospital- Molly Center diabetes education in comparison to \*standard Children's Hospital- Molly Center diabetes education. (standard diabetes education consists of paper based reading material and nursing education).
Interventions
- OTHER Molly Center Diabetes Care Guide (Paper-based)
- OTHER Tablet based interactive diabetes education modules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-04-17 |
| Est. Completion | 2025-04-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03534193
The ClinicalTrials.gov registry entry for NCT03534193 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Molly Center Diabetes Care Guide (Paper-based) is the first listed.
NCT03534193 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03534193 about?
NCT03534193 is a clinical study titled "Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes". This is a prospective, randomized trial to evaluate the effectiveness of using educational modules accessed through a bedside tablet in patients newly diagnosed with Type 1 Diabetes as an adjunct to \*standard Children's Hospital- Molly Center diabetes education in comparison to \*standard Children'...
What is the current status of trial NCT03534193?
This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2017-04-17. Estimated completion is 2025-04-08.
What interventions are being tested in trial NCT03534193?
The interventions under investigation include: Molly Center Diabetes Care Guide (Paper-based) (OTHER), Tablet based interactive diabetes education modules (OTHER).
Who is sponsoring clinical trial NCT03534193?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.